Related Experiment Videos
In-house diabetes program delivers on a 'shoestring' budget
Disease Management Advisor
|February 15, 2003
Summary
Companion HealthCare developed cost-effective, in-house Disease Management (DM) programs. These programs achieved significant clinical results, proving cheaper than external vendor models.
Area of Science:
- Healthcare Management
- Health Services Research
Background:
- Many healthcare organizations utilize external vendors for Disease Management (DM) programs.
- Vendor-based DM programs can be costly to implement and maintain.
- Evaluating alternative DM program structures is essential for cost-efficiency and effectiveness.
Purpose of the Study:
- To assess the efficacy and cost-effectiveness of an in-house Disease Management (DM) program.
- To compare the outcomes of an in-house DM program with traditional vendor-based models.
- To demonstrate the potential for significant clinical returns with limited funding.
Main Methods:
- Development and implementation of an in-house Disease Management (DM) program by Companion HealthCare.
- Internal funding model described as "on a shoestring" to highlight cost constraints.
- Focus on achieving clinical returns within a restricted budget.
Main Results:
- Impressive clinical results were achieved through the in-house DM programs.
- Implementation costs were significantly lower compared to vendored DM models.
- The program demonstrated high value despite limited financial investment.
Conclusions:
- In-house Disease Management (DM) programs can be a highly effective and cost-efficient alternative to vendor-based solutions.
- Significant clinical outcomes are achievable even with constrained financial resources.
- Companion HealthCare's model offers a scalable and economical approach to improving patient care through DM.